SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant - Konno, Yoriyuki; Kimura, Izumi; Uriu, Keiya; Fukushi, Masaya; Irie, Takashi; Koyanagi, Yoshio; Sauter, Daniel; Gifford, Robert J.; Nakagawa, So; Sato, Kei (Cell reports (Cambridge), 2020)
Keywords: Adult; Amino Acid Sequence - genetics; Animals; Betacoronavirus - genetics; Betacoronavirus - immunology; Chiroptera - virology; Codon, Nonsense - genetics; Coronavirus Infections - pathology; Coronavirus Infections - virology; COVID-19; Eutheria - virology; evolution; Humans; Interferon Type I - antagonists & inhibitors; Male; ORF3b; Pandemics; Pneumonia, Viral - virology; SARS-CoV-2; type I interferon; Viral Regulatory and Accessory Proteins - genetics; Viral Regulatory and Accessory Proteins - metabolism; COVID-19; type I interferon; SARS-CoV-2; evolution; ORF3b